D 23980
Latest Information Update: 17 Aug 2001
At a glance
- Originator ASTA Medica [CEASED]
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 17 Aug 2001 Discontinued-Preclinical for Cancer in Germany (Unknown route)
- 01 Dec 1998 New profile
- 01 Jun 1998 Preclinical development for Cancer in Germany (Unknown route)